Drug intelligence / Profile preview

bifid triple viable probiotic

Development stage
Unknown
Lead developer
Shanghai Xinyi Bailuda Pharmaceutical
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Bifid triple viable probiotic is a microbial therapeutic preparation composed of three specific strains of live bacteria: *Bifidobacterium longum*, *Lactobacillus acidophilus*, and *Enterococcus faecalis*. It is widely used in clinical practice to regulate the balance of intestinal microflora and treat gastrointestinal disorders such as diarrhea, constipation, and abdominal distension. The mechanism of action involves the replenishment of beneficial bacteria, which helps to inhibit the growth of pathogenic microorganisms, maintain the integrity of the intestinal mucosal barrier, and modulate local immune responses. In oncology, it is being investigated for its potential to prevent radiation-induced enteritis in patients receiving pelvic radiotherapy for gynecological cancers, such as cervical and endometrial cancer, by mitigating the inflammatory damage to the gut microbiome and improving nutritional status.

Brand names
PeifeikangBifid Triple Viable Capsules
Other names
Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis triple viable preparationBifidobacterium triple viable capsulesShuangqi Ganjun Sanlian Huojun
02

Targets

TLR2 (Toll-like Receptor 2)

Beyond the preview

Go deeper on bifid triple viable probiotic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bifid triple viable probiotic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call